TARC and IgE concetration before and after anti-virus treatment in dermatitis patients positive by Tzank test

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1031220349

Enrollment

350

Registered

2022-09-27

Start date

2022-11-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dermatitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients with dermatitis that dermatitis was diagnosed, and performed TARC and IgE blood test

Exclusion criteria

Exclusion criteria: Patients with each blood test of TARC and IgE only for once

Design outcomes

Primary

Measure	Time frame
Change of anteroposterior TARC and IgE density receiving the antiviral agent	—

Contacts

Public ContactYukiko Wagatsuma

University of Tsukuba

ywagats@md.tsukuba.ac.jp+81-29-853-3489

Outcome results